Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

Prescribing oral chemotherapy

Sandeep D Parsad, Mark J Ratain

BMJ (Clinical Research Ed.)

|February 27, 2007

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ivonescimab: The Next United States Food and Drug Administration Project Optimus Flashpoint?

JTO clinical and research reports·2026

Same author

Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation.

Clinical and translational science·2026

Same author

<i>TPMT</i>-Cisplatin: Lessons in Citation Integrity and Scientific Oversight.

JCO oncology practice·2026

Same author

Dear Doctor: We Still Have No Idea of What Dose of Capecitabine You Should Prescribe.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Same author

Potential alternative dosage strategies for patent-protected oral cancer drugs.

European journal of cancer (Oxford, England : 1990)·2025

Related Experiment Videos

Prescribing oral chemotherapy

Related Concept Videos

Related Articles

Ivonescimab: The Next United States Food and Drug Administration Project Optimus Flashpoint?

Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation.

<i>TPMT</i>-Cisplatin: Lessons in Citation Integrity and Scientific Oversight.

Dear Doctor: We Still Have No Idea of What Dose of Capecitabine You Should Prescribe.

Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer.

Potential alternative dosage strategies for patent-protected oral cancer drugs.